Journal of Leukemia
Open Access

Abstract

Plasma cell leukemia

Oliver Elijanh

Plasma cell leukemia (PCL) may be a plasmacyte dyscrasia, i.e. a disease involving the malignant degeneration of a subtype of white blood cells called plasma cells. it's the terminal stage and most aggressive sort of these dyscrasias, constituting 2% to 4% of all cases of plasmacyte malignancies. PCL may present as primary plasmacyte leukemia, i.e. in patients without prior history of a plasmacyte dyscrasia or as secondary plasmacyte dyscrasia, i.e. in patients previously diagnosed with a history of its predecessor dyscrasia, myeloma. the 2 sorts of PCL appear to be a minimum of partially distinct from one another . Altogether cases, however, PCL are a particularly serious, life-threatening, and therapeutically challenging disease.